Grants Funded
Grant applicants for the 2024 cycle requested a total of nearly $3 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated more than 100 grant applications on the following topics:
The PSF awarded research grants totaling over $650,000 dollars to support more than 20 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
Evaluating Muscle Regeneration Using a Cell Enhanced Amniotic Membrane Allograft
Anand Kumar MD
2020
Case Western Reserve University - School of Medicine
PSF/MTF Biologics Allograft Tissue Research Grant
Tissue Engineering, General Reconstructive
Project Summary: Volumetric muscle loss (VML) is associated with significant functional and aesthetic deficits. The current options for treatment of VML include acellular biological scaffolds (ACellR) and muscle/tendon transfers. These treatments are limited scarring or by donor site morbidity respectively. There remains an unmet need for functional muscle regeneration. Our group has developed, validated, and published a critical sized muscle defect capable of studying various collagen scaffolds including cell augmented scaffolds. Our approach takes advantage of the inherent heterogeneity of MDPCs, which contain both myogenic and angiogenic elements, for optimal skeletal muscle regeneration. In the proposed grant, we seek to test a cell enhanced amniotic membrane scaffold with florescent lineage specific cell tracking technology in our validated VML model. We expect to regenerate a greater volume of functionally polarized muscle with minimal fibrosis compared to collagen scaffolds. Additionally, we seek to further characterize the mechanisms of cell mediated tissue regeneration and defect repopulation using a novel florescent cell tracking technology (Rosa26-CAG-Brainbow2.1/Confetti derived cells). Impact Statement: Volumetric muscle loss (VML) is associated with significant morbidity in both civilian and military populations. Current treatments are limited and thus a translational regenerative solution that minimizes donor morbidity and regenerates functionally polarized tissue is timely and necessary. Our proposed research is an impactful and logical step forward towards our stated goal of healing VML defects and further the understanding of basic cellular repopulation mechanisms within the tissue defect using a florescent lineage specific cell tracking technology (Rosa26-CAG-Brainbow2.1/Confetti derived cells) within our murine model. These critical and sequential steps are necessary steps prior to pragmatic upscaling in a large animal model.
